Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Karyotyping + QF-PCR (Basic) + CMA (750K) + MCC Package is 21 days.

What are the prerequisites for the test Karyotyping + QF-PCR (Basic) + CMA (750K) + MCC Package

  • Karyotyping: None
  • QF-PCR (Basic): None
  • CMA (750K): None
  • MCC Package: None

What are the measure values for the test Karyotyping + QF-PCR (Basic) + CMA (750K) + MCC Package

  • Karyotyping: $500
  • QF-PCR (Basic): $300
  • CMA (750K): $700
  • MCC Package: $1000

What does this test Karyotyping + QF-PCR (Basic) + CMA (750K) + MCC Package identify?

  1. Karyotyping: This test examines the number, size, and shape of chromosomes in a sample of cells. It can identify chromosomal abnormalities such as deletions, duplications, translocations, and inversions.
  2. QF-PCR (Basic): Quantitative Fluorescent Polymerase Chain Reaction (QF-PCR) is used to detect common aneuploidies, such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome), by analyzing specific regions of chromosomes.
  3. CMA (750K): Chromosomal Microarray Analysis (CMA) is a high-resolution genetic test that can detect submicroscopic chromosomal imbalances, including deletions and duplications, across the entire genome. The 750K refers to the number of probes used in the test.
  4. MCC Package: This comprehensive package combines the results of Karyotyping, QF-PCR, and CMA to provide a detailed analysis of chromosomal abnormalities and genetic variations. It is particularly useful for diagnosing genetic disorders, identifying the cause of birth defects, and assessing the risk of genetic conditions in individuals.

Why is this test Karyotyping + QF-PCR (Basic) + CMA (750K) + MCC Package taken?

  • Karyotyping: This test is taken to examine the chromosomes in a person's cells in order to detect any abnormalities or genetic disorders. It involves analyzing the size, shape, and number of chromosomes to diagnose conditions such as Down syndrome, Turner syndrome, and Klinefelter syndrome.
  • QF-PCR (Basic): This test is a quick and accurate method for detecting common chromosomal abnormalities, such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). It is often used in conjunction with karyotyping to provide additional information.
  • CMA (750K): Chromosomal Microarray Analysis (CMA) is a high-resolution genetic test that can detect submicroscopic chromosomal abnormalities. It can identify deletions, duplications, and other genetic variations that may not be visible through karyotyping or QF-PCR.
  • MCC Package: This comprehensive package combines multiple genetic tests to provide a more thorough evaluation of a person's genetic makeup. By including karyotyping, QF-PCR, and CMA, the MCC Package offers a comprehensive assessment of chromosomal abnormalities and genetic disorders.

Popular FAQs on Test

The package includes Karyotyping, QF-PCR (Quantitative Fluorescent Polymerase Chain Reaction), Chromosomal Microarray Analysis (CMA) with 750K resolution, and Maternal Cell Contamination (MCC) testing.
Karyotyping is a test that examines the chromosomes for abnormalities in number, size, shape, and structure.
QF-PCR is a rapid genetic test used to detect common chromosomal abnormalities, such as trisomy 21 (Down syndrome), trisomy 18, and trisomy 13.
CMA is a high-resolution genetic test that can detect submicroscopic chromosomal abnormalities, such as deletions, duplications, and rearrangements.
MCC testing is done to ensure that the results of genetic testing are accurate by confirming that the sample analyzed is from the fetus and not contaminated by maternal cells.
The results of the test are typically available within 2-3 weeks after the sample is collected.

Customer Google Rating